Jianmin Pharmaceutical Group Co.,Ltd. (SHA:600976)
China
· Delayed Price · Currency is CNY 31.93
+0.38 (1.20%)
Mar 10, 2026, 3:00 PM CST
SHA:600976 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Jan '21 Jan 1, 2021 | 2020 - 2016 |
| Market Capitalization | 4,898 | 6,394 | 9,916 | 7,551 | 11,989 | 3,895 | Upgrade
|
| Market Cap Growth | -23.81% | -35.52% | 31.31% | -37.01% | 207.81% | 42.88% | Upgrade
|
| Enterprise Value | 3,912 | 5,531 | 9,131 | 6,672 | 11,258 | 3,392 | Upgrade
|
| Last Close Price | 31.93 | 40.80 | 62.52 | 46.90 | 73.07 | 23.31 | Upgrade
|
| PE Ratio | 14.81 | 17.65 | 19.02 | 18.50 | 39.27 | 26.35 | Upgrade
|
| Forward PE | - | 15.25 | 15.25 | 15.25 | 15.25 | 15.25 | Upgrade
|
| PS Ratio | 1.54 | 1.82 | 2.35 | 2.07 | 3.63 | 1.59 | Upgrade
|
| PB Ratio | 1.88 | 2.61 | 4.39 | 4.05 | 8.06 | 2.94 | Upgrade
|
| P/TBV Ratio | 1.92 | 2.66 | 4.47 | 4.13 | 8.28 | 3.01 | Upgrade
|
| P/FCF Ratio | 30.53 | 56.10 | 48.63 | 51.06 | 62.52 | 48.71 | Upgrade
|
| P/OCF Ratio | 18.31 | 27.29 | 36.95 | 34.98 | 48.36 | 31.03 | Upgrade
|
| EV/Sales Ratio | 1.23 | 1.58 | 2.17 | 1.83 | 3.41 | 1.38 | Upgrade
|
| EV/EBITDA Ratio | 22.45 | 38.10 | 26.38 | 22.62 | 47.72 | 45.60 | Upgrade
|
| EV/EBIT Ratio | 29.22 | 49.56 | 29.16 | 25.39 | 54.27 | 63.18 | Upgrade
|
| EV/FCF Ratio | 24.38 | 48.53 | 44.78 | 45.11 | 58.71 | 42.42 | Upgrade
|
| Debt / Equity Ratio | 0.05 | 0.07 | 0.05 | 0.03 | 0.05 | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | 0.68 | 1.16 | 0.32 | 0.18 | 0.30 | 0.27 | Upgrade
|
| Debt / FCF Ratio | 0.74 | 1.54 | 0.56 | 0.36 | 0.37 | 0.25 | Upgrade
|
| Net Debt / Equity Ratio | -0.39 | -0.38 | -0.39 | -0.43 | -0.52 | -0.42 | Upgrade
|
| Net Debt / EBITDA Ratio | -5.98 | -6.48 | -2.56 | -2.74 | -3.26 | -7.49 | Upgrade
|
| Net Debt / FCF Ratio | -6.26 | -8.26 | -4.34 | -5.46 | -4.01 | -6.96 | Upgrade
|
| Asset Turnover | 0.74 | 0.83 | 1.11 | 1.16 | 1.25 | 1.13 | Upgrade
|
| Inventory Turnover | 3.88 | 4.56 | 5.60 | 7.06 | 8.34 | 8.03 | Upgrade
|
| Quick Ratio | 1.34 | 1.20 | 1.18 | 1.16 | 1.17 | 1.10 | Upgrade
|
| Current Ratio | 1.59 | 1.49 | 1.49 | 1.50 | 1.41 | 1.42 | Upgrade
|
| Return on Equity (ROE) | 13.25% | 15.63% | 25.39% | 24.22% | 21.77% | 11.75% | Upgrade
|
| Return on Assets (ROA) | 1.96% | 1.65% | 5.14% | 5.22% | 4.92% | 1.54% | Upgrade
|
| Return on Invested Capital (ROIC) | 7.95% | 7.26% | 23.62% | 27.42% | 25.02% | 6.67% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.90% | 4.40% | 13.50% | 13.80% | 13.50% | 4.00% | Upgrade
|
| Earnings Yield | 6.66% | 5.67% | 5.26% | 5.40% | 2.55% | 3.79% | Upgrade
|
| FCF Yield | 3.28% | 1.78% | 2.06% | 1.96% | 1.60% | 2.05% | Upgrade
|
| Dividend Yield | 2.85% | 2.21% | 1.92% | 2.13% | 1.10% | 1.57% | Upgrade
|
| Payout Ratio | 43.24% | 51.83% | 29.95% | 30.39% | 19.20% | 21.07% | Upgrade
|
| Buyback Yield / Dilution | 1.31% | 0.49% | -0.43% | -0.26% | 1.35% | -0.96% | Upgrade
|
| Total Shareholder Return | 4.13% | 2.69% | 1.49% | 1.87% | 2.45% | 0.61% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.